Skip to main content

Table 1 Attributes and levels used for the choice-based conjoint analysis

From: Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany

Attributes

Factor levels

Level 1

Level 2

Level 3

Level 4

1.

Ability to self-care

No assistance required for activities of daily living

Little assistance required for activities of daily living

A lot of assistance required for activities of daily living

Complete assistance required for activities of daily living; bed-ridden

2.

Treatment tolerability (adverse reactions)

No or mild adverse reactions possible; no hospitalization required

Moderate adverse reactions possible; manageable without hospitalization

Severe adverse reactions possible; hospitalization for 3–4 days may be required

Very severe to life-threatening adverse reactions possible; hospitalization for ≥5 days may be required

3.

Survival benefit (vs. standard of care)

No additional survival benefit

Survival benefit of approximately 1 additional month

Survival benefit of approximately 2 additional months

Survival benefit of approximately 3 additional months